Relatório global de análise do tamanho, quota e tendências do mercado de dispositivos contracetivos intra-uterinos – Visão geral do setor e previsão para 2031

Análise de mercado de dispositivos contracetivos intrauterinos

Nos últimos anos, mais de metade das gravidezes são indesejadas, involuntárias e inoportunas. Vários governos e organizações sem fins lucrativos estão a aumentar as iniciativas para promover o uso de DIU. Estão a ser organizados vários programas de sensibilização para educar as pessoas sobre as medidas de controlo da natalidade e de planeamento familiar.

Tamanho do mercado de dispositivos contracetivos intra-uterinos

O tamanho global do mercado de dispositivos contracetivos intra-uterinos foi avaliado em 4,48 mil milhões de dólares em 2023 e deverá atingir os 6,47 mil milhões de dólares até 2031, com um CAGR de 4,70% durante o período de previsão de 2024 a 2031.

Âmbito do relatório e segmentação de mercado       

Definição de mercado de dispositivos contracetivos intrauterinos

Intrauterine devices (IUDs) are defined as copper birth control or small T-shaped plastic devices that are inserted into the uterus. These devices are known to prevent pregnancy as it stops sperm from reaching and fertilizing the eggs. These devices are being highly deployed as they are considered safe, long-acting, effective and eliminating the need for other contraceptives.

Intra-Uterine Contraceptive Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Rise in Awareness

The rise in awareness regarding the birth control measures and family planning across the globe acts as one of the major factors driving the growth of intra-uterine contraceptive devices market.

• Initiatives by Government

The increase in the initiatives by several governments and non-profit organizations to promote the use of IUDs accelerate the market growth.

• Affordable Care Act (ACA)

The repealing Affordable Care Act (ACA) in the United States encouraging large section of women to choose for long-acting reversible contraception (LARC) owing to the lack of access to abortion further influence the market.

Opportunities

Furthermore, technological innovations leading to effective contraception and fewer side effects extend profitable opportunities to the market players in the forecast period of 2024 to 2031.

Restraints/Challenges

On the other hand, common risks associated with intrauterine contraceptive devices such as, infections, damage to the uterus and severe cramping, among others are expected to obstruct market growth. Also, stringent regulations and reimbursement policies are projected to challenge the intra-uterine contraceptive devices market in the forecast period of 2024-2031.

This intra-uterine contraceptive devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on intra-uterine contraceptive devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Intra-Uterine Contraceptive Devices Market

The COVID-19 pandemic had an impact on the health systems across the globe, disrupting access to family planning information and services, also affecting intra-uterine contraceptive devices market. The need for family planning remains the same despite this disruption as family planning is critical health care for women. Governments were working with global partners in order to ensure family planning remains an essential element of the global health agenda during pandemic, as well as post-pandemic.

Intra-Uterine Contraceptive Devices Market Scope

The intra-uterine contraceptive devices market is segmented on the basis of type, product type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Hormonal Intrauterine Device
• Copper Intrauterine Device

Product Type

• Mirena
• Skyla
• Paragard
• Essure
• Levosert
• Others

End User

• Hospitals
• Gynecology Clinics
• Community Health Care Centers
• Others

Intra-Uterine Contraceptive Devices Market Regional Analysis

The intra-uterine contraceptive devices market is analyzed and market size insights and trends are provided by country, type, product type and end user as referenced above.

The countries covered in the intra-uterine contraceptive devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the intra-uterine contraceptive devices market because of the technological advancements in intrauterine contraceptive devices within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the rise in awareness among the woman population in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado de dispositivos contracetivos intra-uterinos também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado de dispositivos contracetivos intra-uterinos, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado de dispositivos contracetivos intra-uterinos. Os dados estão disponíveis para o período histórico 2010-2020.

Participação no mercado de dispositivos contracetivos intrauterinos

O panorama competitivo do mercado de dispositivos contracetivos intrauterinos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado dos dispositivos contracetivos intra-uterinos.

Os líderes de mercado Dispositivos contracetivos intra-uterinos que operam no mercado são:

• Teva Pharmaceutical Industries Ltd. (Jerusalém)
• Bayer (Alemanha)
• EUROGINE (Espanha)
• (EUA)
• (EUA)
• HLL Lifecare Limited (Thiruvananthapuram)
• (Israel)
• Prosan International BV (Holanda)
• Melbea Innovations (Hungria)
• Allergan, Merck & Co., Inc.
• DKT Internacional (EUA)
• Medisafe Distribution Inc. (Canadá)
• Medicamentos360 (EUA)
• Pregna International Limited (Índia)
• Egemen Internacional (Turquia)

Últimos desenvolvimentos no mercado de dispositivos contracetivos intrauterinos

• Em junho de 2021, a Sebela Pharmaceuticals Inc. colaborou com a PRA Health Sciences para conduzir um ensaio clínico de fase III para avaliar o LevoCept. O produto é um sistema intrauterino reversível de ação prolongada para segurança, tolerabilidade e eficácia contracetiva. O julgamento será concluído

SKU-2012